Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Conatus Pharmaceuticals Inc. (CNAT)

0.3384   0.008 (2.55%) 11-19 12:30
Open: 0.3315 Pre. Close: 0.33
High: 0.34 Low: 0.3312
Volume: 120,741 Market Cap: 11M
Conatus Pharmaceuticals Inc is a biotechnology company. It focuses on the development and commercialization of novel medicines to treat liver disease.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.331 - 0.332 0.332 - 0.334
Low: 0.316 - 0.318 0.318 - 0.32
Close: 0.327 - 0.33 0.33 - 0.333

Technical analysis

as of: 2019-11-19 11:56:44 AM
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 0.43     One year: 0.47
Support: Support1: 0.32    Support2: 0.27
Resistance: Resistance1: 0.37    Resistance2: 0.40
Pivot: 0.34
Moving Average: MA(5): 0.33     MA(20): 0.34
MA(100): 0.33     MA(250): 1.11
MACD: MACD(12,26):     Signal(9):
Stochastic oscillator: %K(14,3): 31.42     %D(3): 27.14
RSI: RSI(14): 48.72
52-week: High: 4.94  Low: 0.25  Change(%): -92.4
Average Vol(K): 3-Month: 67372  10-Days: 27238

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CNAT has closed above bottom band by 43.0%. Bollinger Bands are 77.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to CNAT's normal range. The bands have been in this narrow range for 89 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Is Conatus Pharmaceuticals Inc.'s (NASDAQ:CNAT) CEO Paid Enough Relative To Peers?
In 2005 Steven Mento was appointed CEO of Conatus Pharmaceuticals Inc. (NASDAQ:CNAT). First, this article will compare…

Caspase 3 Market Comprehensive Study by Leading Players- Aptose Biosciences, BeyondSpring Pharmaceuticals, Conatus Pharmaceuticals
Nov 02, 2019 (HTF Market Intelligence via COMTEX) -- An extensive analysis of the Global Caspase 3 market strategy of the leading companies in the precision…

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 33.17
Shares Float (M) 32.33
% Held by Insiders 3.34
% Held by Institutions 24.84
Shares Short (K) 1270
Shares Short P. Month (K)

Stock Financials

EPS -0.385
Book Value (p.s.) 0.660
PEG Ratio -0.02
Profit Margin -43.92
Operating Margin -46.04
Return on Assets (ttm) -19.5
Return on Equity (ttm) -65.1
Qtrly Rev. Growth -56.0
Gross Profit (p.s.) -0.235
Sales Per Share
EBITDA (p.s.) -0.395
Qtrly Earnings Growth
Operating Cash Flow (M) -27.26
Levered Free Cash Flow (M) -19.75

Stock Valuations

P/E -0.88
P/E Growth Ratio 0.02
P/BV 0.51
P/S 0.38
P/CF -0.41

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.